Remove 2008 Remove Development Remove Marketing Remove Pharmaceuticals
article thumbnail

Guest Post: Talk is Cheap!

Lead on Purpose

Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products. Posted on September 8, 2009 by Michael Ray Hopkin Make communication with employees your priority during times of economic adversity By Albert J.

Committee 140
article thumbnail

No Pain, No Gain. Life Lesson on Endurance

QAspire

He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. “ You get almost nothing without going through some kind of pain, unless you win a lottery.”, replied the man who was himself a fitness freak. He neither had space nor money to start out.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Developing Global Leaders Is America's Competitive Advantage

Harvard Business Review

As global companies focus their strategies on developed and emerging markets, they require substantial cadres of leaders capable of operating effectively anywhere in the world. American companies and academic institutions possess unique competitive advantages in developing these global leaders.

article thumbnail

Big Pharma's Mixed Modes of Growth

Harvard Business Review

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves.

article thumbnail

New Report: We're Not As Connected As We Think

Harvard Business Review

Capital markets are fragmenting and while merchandise trade recovered strongly since 2009, the intensity of services trade has remained stagnant. We compare the depth and breadth of 20 industries' global connectedness before delving into three case studies: pharmaceuticals, passenger cars and mobile phones.

Report 15
article thumbnail

A Quiet Revolution in Clean-Energy Finance

Harvard Business Review

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1.

Energy 10
article thumbnail

India Remakes Global Innovation

Harvard Business Review

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. This lab isn't located in Bangalore or Hyderabad (where Dr Reddy's is headquartered) but in.